Skip to content
OpenCapital
Get started

Treace Medical Concepts, Inc. TMCI Cash & Equivalents

Cash & Equivalents at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$21.69B-43.6%
Stryker logo
StrykerSYK
$2.88B+24.1%
CONMED logo
CONMEDCNMD
$35.03M-1.3%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$424.2M-69.4%
Enovis logo
EnovisENOV
$33.13M-13.9%
OrthoPediatrics logo
OrthoPediatricsKIDS
$14.25M-59.8%

Other financials

Income statement

See full
Revenue$47.2M-10.2%
Gross profit$37.4M-10.7%
Operating income-$17.2M-10.2%
Net income-$18.0M-12.8%
EPS (diluted)-$0.28-12.0%

Balance sheet

See full
Total debt$71.6M+3.2%
Total equity$77.2M-26.7%
Total assets$184.1M-10.6%

Cash flow

See full
Operating cash flow$7.2M+72.5%
CapEx$3.1M-13.6%
Free cash flow$4.2M+538%

Valuation

See full
Market cap$258.19M-26.6%
Enterprise value$320.25M-22.6%
P/S1.3×-0.4×

Profitability

See full
Gross margin79.7%-0.5pp
Operating margin-26.9%+2.5pp
Net margin-29.4%+6.1pp
FCF margin-12.5%-2.8pp

Returns & leverage

See full
Return on equity-66.9%+57.5pp
Debt / equity0.9×+0.3×
Current ratio3.6×-0.9×

Where this comes from

Reported directly by Treace Medical Concepts, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Treace Medical Concepts, Inc.'s cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Treace Medical Concepts, Inc.'s cash & equivalents?
Treace Medical Concepts, Inc. (TMCI) reported cash & equivalents of $9.54M in Q1 2026.
How has Treace Medical Concepts, Inc.'s cash & equivalents changed year-over-year?
Treace Medical Concepts, Inc.'s cash & equivalents decreased by 28.6% year-over-year, from $13.37M to $9.54M.
What is the long-term trend for Treace Medical Concepts, Inc.'s cash & equivalents?
Over 5 years (2020 to 2025), Treace Medical Concepts, Inc.'s cash & equivalents has grown at a 84.4% compound annual growth rate (CAGR), from $502K to $10.71M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.